The cardioprotective effect of SGLT2 inhibition, which is responsible for the reabsorption of sodium and glucose in the proximal tubules of the kidney, has reaffirmed the significance of CRS in the pathogenesis of heart failure and CKD. This evidence concerns the gene SLC5A2 and congenital rubella syndrome.